TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

Skip to content

TD Securities
Client Portals

Capabilities
Sectors
Get To Know
Join Our Team

Search

Search query

TD Securities
Client Portals

Search query

Home
Get to Know TD Cowen
Transactions

$325 Million

Blueprint Medicines

Follow-on Offering

Bookrunner, January 2020

Blueprint Medicines

Blueprint Medicines is a precision therapy company striving to improve human health.

Related Topics

Biotechnology Blueprint Medicines Equity Capital Markets Health Care North America

More Like This

Mar 2024

$600 Million

Follow-on Offering

Bookrunner

Mar 2024

$420 Million

Follow-on Offering

Bookrunner

Feb 2024

$296 Million

Follow-on Offering

Bookrunner

Capabilities
Sectors
Get to Know TD Cowen
Join Our Team

Get In Touch

Headquarters – New York

+1-646-562-1010

View All Locations

@TDCowen
@TDCowenResearch

© 2024, Cowen Inc., All Rights Reserved Regulatory Disclosures FINRA Broker Check Terms of Use Notice for Non-U.S. Investors Privacy

In order to optimize our website for you and to be able to continuously improve it, we use cookies. By continuing to use the website, you agree to the use of cookies. Further information on cookies can be found in our Privacy Policy.